RLS-1496
Asset
Targets GPX4 to induce ferroptosis in senescent cells.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- GPX4
- 5
- Indications
- 2
- Trials
- 1
- Developer
Indications
5Actinic keratosis
Phase 2, rubedolife.com, 10 Oct 2026
Hair loss
Phase 2, rubedolife.com, 10 Oct 2026
Atopic dermatitis
Phase 1, longevity.technology, 13 Oct 2026
2 more
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials2
- Evidence for its targets3
- Competitors9
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.